Great West Life Assurance CO Krystal Biotech, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 26,754 shares of KRYS stock, worth $5.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,754
Previous 26,776
0.08%
Holding current value
$5.04 Million
Previous $4.87 Million
14.0%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$744 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$543 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$496 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$241 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$166 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.84B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...